Table 2 Characteristics of measurements changes of SSc patients at baseline (Day 0) and 1, 3, 6 and 12-month-follow-up.

From: Role and effectiveness of complex and supervised rehabilitation on overall and hand function in systemic sclerosis patients—one-year follow-up study

Parameter

Day 0

P*

Month 1

P*

Month 3

P*

Month 6

P*

Month 12

P*

P†

SSc

Control

SSc

Control

SSc

Control

SSc

Control

SSc

Control

DASH

49.4 (11.8)

52.3 (10.7)

0.5197

33.1 (9.6)

50.3 (10.4)

0.0002

36.3 (10.4)

53.1 (10.7)

0.0006

42.6 (11.5)

53.4 (10.6)

0.0209

48.3 (12.7)

53.8 (10.9)

0.2500

0.0001

VAS

5.3 (1.5)

5.3 (1.1)

1.0000

2.9 (1.1)

4.7 (1.1)

0.0003

3.3 (1.2)

5.0 (1.0)

0.0006

4.1 (1.2)

5.0 (1.0)

0.0582

5.1 (1.7)

5.4 (0.9)

0.3906

0.0001

CHFS

42.3 (11.0)

41.2 (12.1)

0.6756

27.9 (7.5)

38.6 (12.0)

0.0026

30.4 (8.2)

41.7 (11.9)

0.0031

36.1 (10.2)

41.5 (11.4)

0.2189

40.6 (10.9)

42.3 (11.9)

0.7573

0.0001

HAQ-DI

1.3 (0.5)

1.4 (0.6)

0.6407

0.9 (0.5)

1.4 (0.6)

0.0323

1.1 (0.7)

1.4 (0.6)

0.0515

1.1 (0.6)

1.5 (0.6)

0.1000

1.3 (0.6)

1.5 (0.5)

0.4499

0.0001

SHAQ

ALL

1.3 (0.5)

1.3 (0.5)

0.6874

0.9 (0.4)

1.3 (0.5)

0.0394

0.9 (0.4)

1.4 (0.5)

0.0205

1.1 (0.5)

1.4 (0.6)

0.1437

1.3 (0.5)

1.4 (0.5)

0.5827

0.0001

RP

1.6 (0.6)

1.3 (0.5)

0.1263

1.1 (0.5)

1.1 (0.5)

0.6639

1.2 (0.5)

1.3 (0.5)

0.4991

1.4 (0.6)

1.4 (0.6)

0.8943

1.6 (0.6)

1.4 (0.5)

0.2644

0.0001

DU

1.7 (0.6)

1.4 (0.5)

0.1615

1.0 (0.5)

1.3 (0.5)

0.1924

1.2 (0.6)

1.4 (0.5)

0.1924

1.5 (0.6)

1.5 (0.4)

0.8811

1.6 (0.6)

1.5 (0.5)

0.7835

0.0001

dFTP dom

5.3 (1.7)

5.6 (1.1)

0.4304

6.0 (1.7)

5.8 (1.1)

0.7233

5.9 (1.6)

5.7 (1.0)

0.7476

5.5 (1.7)

5.6 (1.0)

0.8161

5.3 (1.8)

5.6 (1.0)

0.6065

0.0001

dFTP ndom

5.3 (1.6)

5.8 (0.8)

0.1869

6.0 (1.5)

6.0 (0.8)

0.7233

5.9 (1.6)

5.9 (0.9)

0.8469

5.6 (1.6)

5.7 (0.9)

0.6182

5.4 (1.6)

5.6 (0.8)

0.3628

0.0001

Kapandi

dom

5.9 (1.4)

5.7 (1.0)

0.6179

7.0 (1.7)

6.7 (1.0)

0.3675

6.7 (1.4)

6.1 (1.3)

0.2466

6.1 (1.5)

5.7 (1.2)

0.4156

5.9 (1.6)

5.4 (1.2)

0.2949

0.0001

ndom

5.9 (1.1)

5.5 (1.4)

0.4689

7.0 (1.4)

5.8 (1.3)

0.0253

6.6 (1.3)

5.5 (1.2)

0.0223

6.1 (1.2)

5.3 (1.3)

0.0628

5.8 (1.2)

5.2 (1.4)

0.1919

0.0001

Hand grip

dom

7.7 (2.8)

8.4 (1.9)

0.7721

8.5 (3.1)

8.6 (1.9)

0.7354

8.2 (3.0)

8.3 (1.6)

0.7476

7.7 (2.9)

8.1 (1.6)

0.9074

7.5 (2.9)

7.9 (1.6)

0.9726

0.0001

ndom

8.1 (2.6)

7.7 (1.7)

0.7844

8.7 (2.8)

7.7 (1.7)

0.3590

8.5 (2.7)

7.5 (1.6)

0.3184

8.1 (2.6)

7.4 (1.6)

0.4648

7.9 (2.5)

7.2 (1.5)

0.4499

0.0001

Hand pinch

dom

3.6 (1.1)

3.7 (1.1)

1.0000

4.1 (1.1)

3.7 (1.2)

0.2738

4.0 (1.1)

3.6 (1.1)

0.3030

3.7 (1.1)

3.5 (1.1)

0.3876

3.6 (1.1)

3.4 (1.1)

0.6092

0.0001

ndom

4.0 (1.0)

3.4 (1.0)

0.0974

4.5 (1.1)

3.5 (1.0)

0.0115

4.4 (1.1)

3.4 (1.0)

0.0126

4.1 (1.0)

3.3 (1.0)

0.0191

4.0 (1.0)

3.3 (1.0)

0.0503

0.0001

  1. Scores of performed tests reported as a mean and ± SD in ().
  2. DASH Disability of the Arm, Shoulder and Hand Questionnaire, VAS visual analog scale, CHFS The Cochin Hand Function Scale, HAQ-DI Health Assessment Questionnaire Disability Index, S-HAQ Scleroderma-HAQ, RP Raynaud’s Phenomenon, DU digital ulcers, dFTP Delta finger-to-palm, dom dominant hand, ndom nondominant hand, Kapandji The Kapandji finger opposition test; P*—p-value for the Manny-Whitney U test indicating significant results according to the Bonferroni correction (p < 0.0033), P†—p-value for the F-Omnibus test of the Friedman ANOVA, only for the study group.
Back to article page